OUR COMPANY
Our Mission
To address a critical gap in the fight against Alzheimer’s Disease by delivering effective risk screening for better detection, earlier treatment, and effective prevention.
Our Vision
A world where everyone over 50 is screened for Alzheimer’s risk, helping turn the tide against the disease through better foresight.
Sensitivity detecting who will be diagnosed with Alzheimer’s.
Screening for disease risk up to 10 years out.
More sensitive than existing screening methods.
Biomarkers used, universally present in common medical records.
Real world patient medical records trained with AI.
An experienced founder and executive with 25 years in medical technologies, including imaging, diagnostics, surgery, mental health, and venture capital. Proven track record of creating value through strategic leadership.
Hayim Raclaw
Director, Chief Executive Officer & Co-founder
Over 15 years in startups, finance, and strategy across Israel, Europe, the US, Canada, and LATAM, including M&A leadership at IMC (NASDAQ: IMCC, CSE: IMCC) with $180M+ in transactions. Reserve pilot in the Israeli Air Force.
Roy Kait
Director, Chief Revenue Officer & Co-founder
Senior Neurologist at Clalit Health Services in Israel and Head of the Cognitive Neurology Service at Beilinson Hospital, Rabin Medical Center, part of the Clalit network. Holds multiple registered patents across various research projects in cognitive neurology.
Dr. Amir Glik, MD
Chief Medical Officer & Co-founder
Founder of the Data Science and AI Research Center and faculty member in the Department of Industrial Engineering and Management at Ariel University. A recognized expert in machine learning, with extensive research and applied AI experience.
Prof. Chen Hajaj
Head of Data Science
& Co-founder
Med-Tech CEO who led a medical imaging company to NASDAQ & TSX IPO before its $500M acquisition by IBM. Co-founded Fio Corporation, pioneering Fionet for diagnostics. MD from UPenn, neurosurgery residency and NIH post-doc at UofT.
Dr. Michael Greenberg, MD
Neurosurgeon, Entrepreneur, PubCo CEO, Experienced company developer
Chief of Biomedical Genetics at Boston University. Led NIH-funded research identifying genetic risk factors for Alzheimer’s. PI of the Framingham Heart Study – Brain Aging Program. Authored 500+ publications. Ph.D. from Indiana University, post-doc at Yale.
Prof. Lindsay A. Farrer, Ph.D.
Leading NIH-funded programs, identified causal factors for AD
Founder & CEO of Datos, a leading patient engagement platform used by Kaiser Permanente and Mayo Clinic. Former GM at NCR and VP at Retalix, with 18 years as a technology executive. BSc and Master’s in Engineering from Technion.
Uri Bettesh
Founder & CEO of Datos, Patient Engagement Platform for Healthcare
